Article info
PDFClinical and epidemiological research
Concise report
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
- Correspondence to Dr V Smith, Department of Rheumatology, Ghent University Hospital 0K12-IB, De Pintelaan 185, B-9000, Gent, Belgium; Vanessa.Smith{at}ugent.be
Citation
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
Publication history
- Accepted December 14, 2008
- First published December 22, 2008.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.